Validation and testing are different things. As a form of verification, testing adds significant value as part of the overall process of validation. Business & Decision Life Sciences understands the importance of good testing practices in delivering business value in support of validation.
Like any other discipline used in the Life Sciences industry, the testing of software is a professional service that can add significant value to companies developing software applications or implementing commercial systems.
Evidence suggests that the Life Sciences industry continues to struggle with applying the concepts of risk-based validation, and nowhere more so than in the use of risk-based testing to deliver better quality software, assure user acceptance of new software and systems, mitigate risks to product quality and patient safety and justifiably reduce project costs.
Life Sciences organizations are looking to reduce their project costs by outsourcing test activities, but need to work with testing organizations who are experienced not only in the discipline of software testing, but specifically in risk-based testing based on the outcome of detailed functional risk assessments.
Business & Decision Life Sciences is recognized as a leading exponent of test best practices in the Life Sciences industry and is heavily involved in the work of the GAMP® Testing Special Interest Group and Test Automation Special Interest Group, and the development of the GAMP® "Testing of GxP Systems" Good Practice Guide.
Leveraging the company's RightDelivery® Global Model, Business & Decision Life Sciences provides a scalable set of services to support Life Sciences companies to test their GxP relevant applications. Services range from the provision of resources to the planning, management and execution of complete test cycles which include: